Concepedia

Author

Yoshiyuki Sugimoto

Kyowa Kirin (Japan)

Also Known As

YOSHIYUKI SUGIMOTO, Yoshiyuki SUGIMOTO, Yoshiyuki Sugimoto

24

Publications

495

Citations

11

H-Index

30

Concepts

All Affiliations

Kyowa Kirin (Japan)Nagoya UniversityThe University of TokyoToray (United States)Toyo University
YS

About

Yoshiyuki Sugimoto is an author at Kyowa Kirin (Japan) specializing in medicine, physiology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

240

2

Cell Biology

2

2

130

3

Gastroenterology

2

2

81

4

Social Sciences

1

1

10

5

Cellular Physiology

1

1

105

Yoshiyuki Sugimoto

×

15

Publications

483

Citations

11

H-Index

YearCitations

Gα <sub>12/13</sub> Mediates α <sub>1</sub> -Adrenergic Receptor–Induced Cardiac Hypertrophy

Yoshiko Maruyama, Motohiro Nishida, Yoshiyuki Sugimoto,

Circulation Research

2002

105

Chronic alcoholism and evolution of pain and prognosis in chronic pancreatitis

Tetsuo Hayakawa, Takaharu Kondo, Tokimune Shibata,

Digestive Diseases and Sciences

1989

70

Discovery of Novel 5,5-Diarylpentadienamides as Orally Available Transient Receptor Potential Vanilloid 1 (TRPV1) Antagonists

Osamu Saku, Hiroshi Ishida, Eri Atsumi,

Journal of Medicinal Chemistry

2012

59

Binding Pockets of the β<sub>1</sub>- and β<sub>2</sub>-Adrenergic Receptors for Subtype-Selective Agonists

Masafumi Isogaya, Yoshiyuki Sugimoto, Ryuji Tanimura,

Molecular Pharmacology

1999

45

Pancreas divisum

Tetsuo Hayakawa, Takaharu Kondo, Tokimune Shibata,

International Journal of Pancreatology

1989

41

Myeloperoxidase-Specific Anti-Neutrophil Cytoplasmic Autoantibodies - Related Scleroderma Renal Crisis Treated with Double-Filtration Plasmapheresis.

Akiko OMOTE, Masahito Muramatsu, Yoshiyuki Sugimoto,

Internal Medicine

1997

32

The therapeutic potential of a novel PSMA antibody and its IL-2 conjugate in prostate cancer.

Yoshiyuki Sugimoto, Maiko Hirota, Kazuhiro Yoshikawa,

PubMed

2014

25

Pr1E11, a novel anti-TROP-2 antibody isolated by adenovirus-based antibody screening, recognizes a unique epitope

Masahiro Ikeda, Miki Yamaguchi, Kazunori Kato,

Biochemical and Biophysical Research Communications

2015

19

Identification of a Key Amino Acid of the β2-Adrenergic Receptor for High Affinity Binding of Salmeterol

Masafumi Isogaya, Yoko Yamagiwa, Shigeo Fujita,

Molecular Pharmacology

1998

19

β1-Selective Agonist (−)-1-(3,4-Dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol [(−)-RO363] Differentially Interacts with Key Amino Acids Responsible for β1-Selective Binding in Resting and Active States

Yoshiyuki Sugimoto, Reiko Fujisawa, Ryuji Tanimura,

Journal of Pharmacology and Experimental Therapeutics

2002

15

Page 1